Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Analysis Correlating the Osteoarthritic Knee Microenvironment to Clinical Outcome After Treatment With Regenexx® SD Treatment: A Multi-Site Study

NCT03898388 is registered in ClinicalTrials.gov with Regenexx, LLC as lead sponsor.

NCT NCT03898388
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03898388 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Analysis Correlating the Osteoarthritic Knee Microenvironment to Clinical Outcome After Treatment With Regenexx® SD Treatment: A Multi-Site Study
Lead sponsor
Regenexx, LLC
Phase
Not applicable
Overall status
Terminated
Start date
March 21, 2019
Completion date
March 30, 2022
Enrollment
47 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

knee osteoarthritis